HOME >> BIOLOGY >> NEWS
Scientists making advances in cancer to receive international awards

as related to drug discovery that has implications for the improved care of cancer patients. The prize was established to honor Dr. Bruce F. Cain, whose scientific interests involved the design, synthesis, and biological evaluation of potential anti-tumor drugs. Adams will present his lecture, "The Proteasome and Cancer: The Discovery and Development of VELCADE," at 9:00 a.m., April 5, in Ballroom A-B of the Washington Convention Center.

Nicholas Edward Day, Ph.D., Professor of Epidemiology, University of Cambridge, UK, will be honored with the 15th AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention. With this award, Day will be recognized for developing and widely applying many of the statistical methods that support modern cancer epidemiology. The award is intended to distinguish outstanding achievements in the fields of epidemiology, biomarkers, and prevention. Day will present his lecture on "Cancer Prevention: Past Perspectives and Future Directions," at 5:30 p.m. on Tuesday, April 4, in Hall D of the Washington Convention Center.

Merrill J. Egorin., M.D., Professor of Medicine and Pharmacology, University of Pittsburgh Cancer Institute, Pittsburgh, Pa., will be honored in recognition of his outstanding achievements in clinical and preclinical cancer pharmacology. Dr. Egorin will be the recipient of the 11th AACR-Joseph H. Burchenal Clinical Research Award, which recognizes outstanding achievements in clinical cancer research. The award's namesake was an honorary member and past president of AACR, as well as a major figure in clinical cancer research. Dr. Egorin's lecture, "Keep on Trucking: Antineoplastic Clinical Pharmacology--Where We Have Been, and Where We Need to Go," is to be presented at 8:00 a.m., Wednesday, April 5, in Ballroom A-B of the Washington Convention Center.

Ivan Dikic, M.D., Ph.D., a professor in the Institute for Biochemist
'"/>

Contact: Yarissa Ortiz
ortiz@aacr.org
215-440-9300
American Association for Cancer Research
24-Mar-2006


Page: 1 2 3 4

Related biology news :

1. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
2. Scientists prove that disputed Korean stem cell line comes from an unfertilized egg and not cloning
3. Scientists move closer to bio-engineered bladders
4. Scientists find stem cell switch
5. Scientists discover new way to study nanostructures
6. Scientists a step closer to understanding how anaesthetics work in the brain
7. Scientists to make news at Computational Biology Conference
8. Accident-prone? Scientists link brain function to knee injuries
9. Scientists take next step in understanding potential target for ovarian cancer treatment
10. Scientists find brown fat master switch
11. Scientists identify 2 distinct Parkinsons networks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2017)... Feb. 6, 2017 According to Acuity ... driving border authorities to continue to embrace biometric ... are 2143 Automated Border Control (ABC) eGates and ... at more than 163 ports of entry across ... 2016 achieving a combined CAGR of 37%. APC ...
(Date:2/2/2017)... NEW YORK , Feb. 2, 2017  EyeLock ... has released a new white paper " What You ... The problem of ensuring user authenticity is a ... protect the authentication of users. However, traditional authentication schemes ... Biometric authentication offers an elegant ...
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
Breaking Biology News(10 mins):
(Date:2/16/2017)...  ArmaGen, Inc., a privately held biotechnology company ... neurological disorders, today reported preliminary evidence of cognitive ... investigational therapy for the treatment of Hurler and ... or MPS I). The initial results from an ... at the 13 th annual WORLD Symposium ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor ... a clinical-stage biotechnology company developing first-in-class biological therapies ... that it has elected to terminate its license ... peptide receptor agonists, including Cenderitide. "Our ... move as we prioritize our efforts to advance ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
(Date:2/16/2017)... SAN DIEGO , Feb. 16, 2017 /PRNewswire/ ... and innovative products to treat a variety of ... $5 million Series 1a financing and entered into ... Bank (SVB).  Dermata intends to use the capital ... of making major advancements in the treatment of ...
Breaking Biology Technology:
Cached News: